ECSP972015A - TETRAHYDROISOQUINALINE DERIVATIVES - Google Patents
TETRAHYDROISOQUINALINE DERIVATIVESInfo
- Publication number
- ECSP972015A ECSP972015A ECSP972015A ECSP972015A EC SP972015 A ECSP972015 A EC SP972015A EC SP972015 A ECSP972015 A EC SP972015A EC SP972015 A ECSP972015 A EC SP972015A
- Authority
- EC
- Ecuador
- Prior art keywords
- lower alkyl
- hydrogen
- derivatives
- hydroxyl
- taken together
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003039 tetrahydroisoquinolinyl group Chemical class C1(NCCC2=CC=CC=C12)* 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere al empleo de los derivados de la tetrahidroisoquinolina de fórmula general (gráfico), en donde A es arilo R1 es hidrógeno, hidroxilo, alquilo inferior, alcoxi inferior, R-Co- ó R-COO-, en donde R es alquilo inferior; R2 es hidrógeno, alquilo inferior o cicloalquilo. R3-R7 son hidrógeno, alquilo inferior, alcoxilo inferior, hidroxilo ó R3 y R4 tomados conjuntamente son -(CH2)n-6. R6 y R7 tomados conjuntamente con -OCH2=-y n es 3 ó 4, así como también las sales farmacéuticamente aceptables para la elaboración de medicamentos para el control o tratamiento de enfermedades que representan indicaciones terapéuticas para los bloqueadores específicos del subtipo de receptores.The present invention relates to the use of the tetrahydroisoquinoline derivatives of the general formula (graph), where A is aryl R1 is hydrogen, hydroxyl, lower alkyl, lower alkoxy, R-Co- or R-COO-, where R it is lower alkyl; R2 is hydrogen, lower alkyl, or cycloalkyl. R3-R7 are hydrogen, lower alkyl, lower alkoxy, hydroxyl, or R3 and R4 taken together are - (CH2) n-6. R6 and R7 taken together with -OCH2 = -y n is 3 or 4, as well as pharmaceutically acceptable salts for the manufacture of drugs for the control or treatment of diseases that represent therapeutic indications for specific blockers of the receptor subtype.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972015 ECSP972015A (en) | 1997-02-03 | 1997-02-03 | TETRAHYDROISOQUINALINE DERIVATIVES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972015 ECSP972015A (en) | 1997-02-03 | 1997-02-03 | TETRAHYDROISOQUINALINE DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972015A true ECSP972015A (en) | 1998-04-07 |
Family
ID=42042849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972015 ECSP972015A (en) | 1997-02-03 | 1997-02-03 | TETRAHYDROISOQUINALINE DERIVATIVES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972015A (en) |
-
1997
- 1997-02-03 EC ECSP972015 patent/ECSP972015A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26276A1 (en) | 1,2,4,5- TETRAHIDRO-BENZO (D) AZEPINAS LAW 17164 | |
| ES2119124T3 (en) | BENZIMIDAZOLES USEFUL FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS. | |
| ES2171109A1 (en) | 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists | |
| UY26782A1 (en) | DERIVATIVES OF BENZOTIAZOLE | |
| GT199800038A (en) | ATROPISOMERS OF 3-ARYL-4 (3H) -QUINAZOLINONES. | |
| CO4810373A1 (en) | ARYL-CONDENSED AZAPOLYCLIC COMPOUNDS | |
| AR004516A1 (en) | DERIVATIVES OF PYRIMIDINE, ITS USE, PROCEDURES TO PREPARE THEM AND MEDICINES THAT CONTAIN THEM | |
| ES2052717T3 (en) | USE OF INDOLONE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF PARKINSON'S DISEASE. | |
| GT199600100A (en) | PROCEDURES FOR MAKING HETERO-CYCLE COMPOUNDS. | |
| ECSP045483A (en) | DERIVATIVES OF BENZOCONDENSED HETEROARILAMIDE OF USEFUL TIENOPIRIDINS AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME, AND METHODS FOR USE | |
| UY26872A1 (en) | DERIVATIVES OF THE 4- PIRIDINE PHENYL | |
| MX9307810A (en) | NON-AROMATIC HETERO CYCLES SUBSTITUTED WITH AMINOMETHYLENE. | |
| UY26086A1 (en) | PROCEDURES AND INTERMEDIATES TO PREPARE ANTI-CANCER COMPOUNDS | |
| ES2149468T3 (en) | DERIVATIVES OF RADICICOL. | |
| ES2112386T3 (en) | THERAPEUTIC AGENTS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE. | |
| PT779284E (en) | NEW 2-NAFTAMIDE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS AS D3 RECEPTOR AGONISTS | |
| ES2141787T3 (en) | 1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE DERIVATIVES. | |
| ES2164465T3 (en) | USE OF REPLACED AMINOMETIL-CHROMANS TO AVOID NEURONAL DEGENERATION AND TO STIMULATE NEURONAL REGENERATION. | |
| AR028475A1 (en) | DERIVATIVES OF AZAINDOL AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DEPRESSION. | |
| HUP9904294A2 (en) | Topiramate derivatives use for producing medicament useful in the treatment of neuropathic pain | |
| ES2111352T3 (en) | USE OF DIESTER PHOSPHATE FOR THE TREATMENT OF RETINAL DISEASES. | |
| AR005613A1 (en) | EMPLOYMENT OF TETRAHYDROISOKINOLINE DERIVATIVES | |
| AR007369A1 (en) | THE USE OF CARBOXYLATED DERIVATIVES AND A MEDICINAL PRODUCT CONTAINING ONE OR MORE OF SUCH DERIVATIVES | |
| ES2142320T3 (en) | 2-PIRAZINYL-ETHYLAMINE DERIVATIVES AND THEIR USE AS PHARMACEUTICAL PRODUCTS. | |
| BR9707335A (en) | 2,3-Benzodiazepine derivatives: their preparation and use as a medicine |